Biom offers a cloud-based bioinformatics platform that accelerates genomic data analysis for drug discovery. Our solution uses advanced algorithms and machine learning to identify potential drug targets from large biological datasets, streamlining research pipelines for life science organizations.
Funding
Funding not disclosed
Founders
Product
Problem
The process of analyzing complex genomic data for drug discovery and development is often time-consuming and requires specialized bioinformatics expertise. This can lead to delays in identifying novel therapeutic targets and hinder the efficient progression of research pipelines.
Solution
Biom provides a cloud-based bioinformatics platform designed to streamline genomic data analysis for life science organizations. Our solution leverages advanced algorithms and machine learning models to accelerate the identification of potential drug targets from large-scale biological datasets. By automating complex analytical workflows, Biom empowers researchers to gain deeper insights into disease mechanisms and expedite the early stages of drug discovery and development.
Target Audience
Our primary customers are pharmaceutical companies, biotechnology firms, and academic research institutions engaged in genomics and drug discovery.
Features
- Cloud-native platform for scalable genomic data analysis.
- Integrated suite of bioinformatics tools for variant calling, annotation, and pathway analysis.
- Machine learning-driven target identification engine for prioritizing potential therapeutic candidates.
- User-friendly interface with customizable analysis pipelines.
- Secure data handling and compliance with relevant industry standards.
- API access for integration with existing research infrastructure.